Isolated cardiac sarcoidosis: A systematic review
Shokoufeh Hajsadeghi1, Elham Piryaie2, Shayan Mirshafiee3
1Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Iran.
Insights
Isolated cardiac sarcoidosis, a heart-exclusive condition, affects men and women equally. This understudied disease presents a poorer prognosis than multi-organ sarcoidosis, necessitating further research.
Area of Science:
- Cardiology
- Immunology
- Rare Diseases
Background:
- Isolated cardiac sarcoidosis is a rare condition affecting only the heart.
- It can lead to severe complications like arrhythmias and heart failure.
- This specific entity remains understudied, lacking systematic reviews.
Purpose of the Study:
- To systematically review the existing literature on isolated cardiac sarcoidosis.
- To characterize the epidemiology, clinical presentation, and outcomes of this condition.
- To identify gaps in knowledge and areas for future research.
Main Methods:
- A systematic literature search was conducted from 1978 to 2025.
- 14 relevant studies, predominantly case series, were included.
- Data on patient demographics, clinical features, and outcomes were extracted and analyzed.
Main Results:
- The condition affects both sexes equally, typically in patients aged 55-65 years.
- Isolated cardiac sarcoidosis is linked to reduced left ventricular ejection fraction and worse survival compared to multi-organ disease.
- Diagnostic criteria variability and potential selection bias were noted limitations.
Conclusions:
- Isolated cardiac sarcoidosis is a distinct and severe clinical entity with limited data.
- Its poorer prognosis highlights the need for specific diagnostic and management guidelines.
- Multicenter studies are crucial for advancing understanding and patient care.
Abstract:
BackgroundIsolated cardiac sarcoidosis is a distinct entity of sarcoidosis characterized by disease confined exclusively to the heart, without involvement of other organs. While cardiac sarcoidosis can lead to severe complications such as arrhythmias and heart failure, isolated cardiac sarcoidosis remains understudied, and no systematic review has previously addressed this condition.Key findings: A systematic review of the literature from 1978 to 2025 identified 14 relevant studies, primarily case series. Isolated cardiac sarcoidosis affects both sexes equally, with most patients aged 55-65 years. Compared with multi-organ cardiac sarcoidosis, isolated cardiac sarcoidosis is associated with lower left ventricular ejection fraction and poorer survival. Variability in diagnostic criteria and potential selection bias were key limitations.ConclusionIsolated cardiac sarcoidosis is a distinct and severe clinical entity with limited available data. Its poorer prognosis underscores the need for specific diagnostic and management guidelines. Future multicenter studies are essential to improve understanding and care for patients with this condition.
More Related Videos
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
